180
Biomédica 2018;38:180-8
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Towards Universal Access to Prevention, Diagnosis and Treatment
Towards a world free of tuberculosis
Это руководство предназначено для использования в качестве пособия дл яврачей и других медицинских работников, осуществляющих лечение и уход за больными лекарст...енно-устойчивым туберкулезом.
more
Revised National Tuberculosis Control Programme